English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The daily exponential increase of biomedical information in scientific literature and patents is a main obstacle to foster advances in biomedical research. A fundamental step hereby is to find key information (named entities) inside these publications applying Biomedical Named Entities Recognition (BNER). However, BNER is a complex task compared to traditional NER as biomedical named entities often have irregular expressions, employ complex entity structures, and don’t consider well-defined entity boundaries, etc. In this paper, we propose a deep neural network (NN) architecture, namely the bidirectional Long-Short Term Memory (Bi-LSTM) based model for BNER. We present a detailed neural network architecture showing the different NN layers, their interconnections and transformations. Based on existing gold standard datasets, we evaluated and compared several models for identifying biomedical named entities such as chemicals, diseases, drugs, species and genes/proteins. Our deep NN based Bi-LSTM model using word and character level embeddings outperforms CRF and Bi-LSTM using only word level embeddings significantly.

Improving Named Entity Recognition for Biomedical and Patent Data Using Bi-LSTM Deep Neural Network Models